Science & Technology · JKCCE Prelims 2024 — General Studies Paper I · Last updated:

View the full solved paper: JKCCE Prelims 2024 — General Studies Paper I

Consider the following statements regarding Sickle cell anaemia:

  • i. It is caused due to genetic mutation.
  • ii. It affects the shape of red blood cells and makes the inability to carry oxygen.
  • iii. It can be treated by bone marrow or stem cell transplantation.
  • iv. Sickle Cell Disease causes the body to make normal haemoglobin

The incorrect statement/s is/are:

  1. A. i only
  2. B. iii only
  3. C. ii and iii only
  4. D. iv only (Correct answer)

Correct Answer

Option D — iv only

Detailed Solution & Explanation

Key Points

  • The question asks for the incorrect statement, and only statement iv is wrong.
  • Statement iv is incorrect. Sickle cell disease causes the body to make abnormal haemoglobin — haemoglobin S, not normal haemoglobin. This is the entire basis of the disease.
  • Statement i is correct. It is caused by a genetic mutation — a single base substitution (GAG to GTG) in the beta-globin gene on chromosome 11, replacing glutamic acid with valine at the sixth position of the beta chain.
  • Statement ii is correct. The abnormal haemoglobin polymerises when deoxygenated, distorting red blood cells into a rigid sickle shape and impairing their capacity to carry oxygen.
  • Statement iii is correct. Bone marrow or stem cell transplantation is currently the only established curative treatment.

Additional Information

  • Inheritance is autosomal recessive. A person with two mutant alleles (HbS HbS) has sickle cell disease; a person with one (HbA HbS) has sickle cell trait, is largely asymptomatic, and is a carrier. Two carriers have a 25% chance of an affected child in each pregnancy.
  • The malaria connection explains the mutation's persistence. **Heterozygous carriers have significant protection against *Plasmodium falciparum* malaria, so the allele is maintained at high frequency in malaria-endemic populations — a textbook case of balancing selection and heterozygote advantage**.
  • Clinical features: chronic haemolytic anaemia, painful vaso-occlusive crises when sickled cells block small vessels, splenic sequestration and eventual autosplenectomy, acute chest syndrome, stroke, and susceptibility to infection.
  • Management includes hydroxyurea, which raises fetal haemoglobin levels, transfusion, folic acid, pain control, penicillin prophylaxis in children, and increasingly gene therapy — CRISPR-based treatments have received approval in several countries.
  • In India, sickle cell disease is concentrated in tribal populations of Madhya Pradesh, Maharashtra, Chhattisgarh, Odisha, Jharkhand and Gujarat. The National Sickle Cell Anaemia Elimination Mission, launched in July 2023 from Shahdol, Madhya Pradesh, aims to eliminate the disease as a public health problem by 2047, through universal screening of about 7 crore people aged up to 40 in affected districts, counselling and card distribution.
  • Do not confuse it with thalassaemia, which is also an autosomal recessive haemoglobin disorder but involves reduced or absent synthesis of globin chains rather than a structurally abnormal haemoglobin.

Topics covered: Biology